---
figid: PMC6482288__401_2018_1930_Fig3_HTML
figtitle: Schematics presenting mechanisms of actions of approved and selected experimental
  cytokine and cytokine receptor agonists and antagonists
organisms:
- NA
pmcid: PMC6482288
filename: 401_2018_1930_Fig3_HTML.jpg
figlink: /pmc/articles/PMC6482288/figure/Fig3/
number: F3
caption: Schematics presenting mechanisms of actions of approved and selected experimental
  cytokine and cytokine receptor agonists and antagonists. a–c TNF (a), IL-1 (b),
  and IL-6 (c) signaling via their receptors and mechanisms of actions of approved
  and selected novel inhibitors. Figures are modified using Protein Lounge Pathway
  Database (www.proteinlounge.com). Ab antibody, gp130 glycoprotein 130, icIL-1Ra
  intracellular interleukin-1 receptor antagonist, IL interleukin, IL-1Ra interleukin-1
  receptor antagonist, IL-1R1 interleukin-1 receptor type 1, IL-1R2 interleukin-1
  receptor type 2, IL-1RAcP IL-1 receptor accessory protein, sIL-1RAcP soluble IL-1
  receptor accessory protein, IL-6R interleukin-6 receptor, sgp130 soluble glycoprotein
  130, solIL-6R soluble interleukin-6 receptor, solTNF soluble tumor necrosis factor,
  tmTNF transmembrane tumor necrosis factor, TNF tumor necrosis factor, TNFR tumor
  necrosis factor receptor
papertitle: Post-stroke inflammation—target or tool for therapy?.
reftext: Kate Lykke Lambertsen, et al. Acta Neuropathol. 2019;137(5):693-714.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.930875
figid_alias: PMC6482288__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6482288__F3
ndex: 397a3de2-de94-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6482288__401_2018_1930_Fig3_HTML.html
  '@type': Dataset
  description: Schematics presenting mechanisms of actions of approved and selected
    experimental cytokine and cytokine receptor agonists and antagonists. a–c TNF
    (a), IL-1 (b), and IL-6 (c) signaling via their receptors and mechanisms of actions
    of approved and selected novel inhibitors. Figures are modified using Protein
    Lounge Pathway Database (www.proteinlounge.com). Ab antibody, gp130 glycoprotein
    130, icIL-1Ra intracellular interleukin-1 receptor antagonist, IL interleukin,
    IL-1Ra interleukin-1 receptor antagonist, IL-1R1 interleukin-1 receptor type 1,
    IL-1R2 interleukin-1 receptor type 2, IL-1RAcP IL-1 receptor accessory protein,
    sIL-1RAcP soluble IL-1 receptor accessory protein, IL-6R interleukin-6 receptor,
    sgp130 soluble glycoprotein 130, solIL-6R soluble interleukin-6 receptor, solTNF
    soluble tumor necrosis factor, tmTNF transmembrane tumor necrosis factor, TNF
    tumor necrosis factor, TNFR tumor necrosis factor receptor
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL1R2
  - APP
  - SUCLA2
  - IL18
  - IL1A
  - TNF
  - IL1RN
  - IL6R
  - TNFRSF1B
  - TRAP
  - ACP5
  - CD40LG
  - TRAF2
  - TRRAP
  - TDRD7
  - SCYL1
  - IL1B
  - TNFRSF1A
  - IL1R1
  - IL1RAP
  - IL6
  - IL6ST
  - NM
  - LRPPRC
  - Pegol
---
